24 November 2017
News and Views
Links and Services
This month's British Journal of Cancer investigates docetaxel with cisplatin and 5-fluorouracil or with capecitabine in esophagogastric cancer.
Docetaxel administered 3-weekly with cisplatin and 5-fluorouracil leads to better survival than d
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors